Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

ClinicalTrials.gov ID: NCT03979313

Public ClinicalTrials.gov record NCT03979313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Late Preterm and Term Infants (MELODY)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy late preterm and term infants who are 35 weeks or greater gestational age and entering their first RSV season.

Study identification

NCT ID
NCT03979313
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
3,012 participants

Conditions and interventions

Eligibility (public fields only)

Age range
0 Years to 1 Year
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 23, 2019 (Actual)
Primary completion
Mar 11, 2021 (Actual)
Completion
Mar 21, 2023 (Actual)
Last update posted
Feb 28, 2024

2019 – 2023

United States locations

U.S. sites
66
U.S. states
32
U.S. cities
62
Facility City State ZIP Site status
Research Site Birmingham Alabama 35205 —
Research Site Fort Defiance Arizona 86504 —
Research Site Fayetteville Arkansas 72703 —
Research Site Anaheim California 92804 —
Research Site Downey California 90240 —
Research Site National City California 91950 —
Research Site Paramount California 90723 —
Research Site West Covina California 91790 —
Research Site Aurora Colorado 80015 —
Research Site Colorado Springs Colorado 80922 —
Research Site Washington D.C. District of Columbia 20016 —
Research Site Gainesville Florida 32653 —
Research Site Hialeah Florida 33012 —
Research Site Miami Florida 33142 —
Research Site Atlanta Georgia 30322 —
Research Site Fort Gordon Georgia 30905 —
Research Site Chicago Illinois 60611 —
Research Site Oak Lawn Illinois 60453 —
Research Site Indianapolis Indiana 46202 —
Research Site West Des Moines Iowa 50266 —
Research Site Bardstown Kentucky 40004 —
Research Site Lexington Kentucky 40517 —
Research Site Shreveport Louisiana 71105 —
Research Site Jackson Mississippi 39216 —
Research Site Columbia Missouri 65212 —
Research Site Lincoln Nebraska 68504 —
Research Site Omaha Nebraska 68114 —
Research Site Gallup New Mexico 87301 —
Research Site Shiprock New Mexico 87420 —
Research Site Syracuse New York 13210 —
Research Site Boone North Carolina 28607 —
Research Site Cincinnati Ohio 45229 —
Research Site Cleveland Ohio 44109 —
Research Site Cleveland Ohio 44121 —
Research Site Columbus Ohio 43205 —
Research Site Dayton Ohio 45406 —
Research Site Dayton Ohio 45414 —
Research Site Oklahoma City Oklahoma 73104 —
Research Site Erie Pennsylvania 16506 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Warwick Rhode Island 02886 —
Research Site North Charleston South Carolina 29406 —
Research Site Sioux Falls South Dakota 57105 —
Research Site Kingsport Tennessee 37660 —
Research Site Memphis Tennessee 38103 —
Research Site Tullahoma Tennessee 37388 —
Research Site Baytown Texas 77521 —
Research Site Dallas Texas 75251 —
Research Site Edinburg Texas 78539 —
Research Site League City Texas 77573 —
Research Site Longview Texas 75605 —
Research Site Pearland Texas 77584 —
Research Site San Antonio Texas 78240 —
Research Site San Antonio Texas 78249 —
Research Site Tomball Texas 77375 —
Research Site Layton Utah 84041 —
Research Site Roy Utah 84067 —
Research Site Salt Lake City Utah 84107 —
Research Site Salt Lake City Utah 84123 —
Research Site South Jordan Utah 84095 —
Research Site St. George Utah 84790 —
Research Site Charlottesville Virginia 22902 —
Research Site Richmond Virginia 23219 —
Research Site Seattle Washington 98105 —
Research Site Morgantown West Virginia 26506 —
Research Site Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 132 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03979313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2024 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03979313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →